# US 2023/0145887 A1 · Ophthalmic implant for delivering therapeutic substances

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0145887 A1
- Document ID: US20230145887A1
- Status: Published application
- Kind: A1
- Application number: 17/974,228
- Filed: 2022-10-26
- Published: 2023-05-11
- Earliest claimed: 2013-03-28
- Assignees: ForSight Vision4, Inc.
- Applicants: ForSight Vision4, Inc.
- Inventors: Signe Erickson; Randolph E. Campbell; Darren Doud
- Web page: https://patentgrep.com/patent/US20230145887A1

## CPC

- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61M 39/0208: {Subcutaneous access sites (implantable infusion devices A61M5/14276; transcutaneous access sites A61M39/0247)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Described are implantable therapeutic devices, systems and methods to treat a patient. The device includes a hollow refillable housing for implantation within the posterior segment of an eye through a penetration in the sclera including a proximal retention structure protruding outward from a proximal end region of the housing, an access portion opening, and a penetrable barrier positioned at least in part within the access portion opening, the penetrable barrier configured to be repeatedly penetrated. A rigid porous structure is positioned within a region of the housing away from the access portion opening into a reservoir chamber extends along an axis between the penetrable barrier and the porous structure includes a volume sized to deliver therapeutic amounts of a therapeutic agent to the eye for an extended period of time. A cover is coupled to at least an upper surface of the proximal retention structure.

## Claims

### Claim at position 1

-19. (canceled)

### Claim 20

A therapeutic device comprising:
a housing configured to be positioned at least partially within a vitreous of the eye upon implantation, the housing comprising a reservoir extending between a proximal end region of the housing and a distal end region of the housing, the distal end region defining an outlet from the reservoir having a rigid porous structure positioned within the outlet and, the reservoir having a volume sized to contain one or more therapeutic agents for delivery through the outlet into the eye for an extended period of time;
a porous structure positioned within the outlet;
a proximal retention structure positioned near the proximal end region of the housing, the retention structure comprising a narrowed portion and a flanged portion extending proximally from the narrowed portion, wherein an access opening of the proximal retention structure extends through the retention structure into the reservoir;
a septum positioned within the access opening, the septum having a first region positioned within at least a portion of the flanged portion and a second region located distal to the first region positioned at least in part within the narrowed portion; and
a cover encapsulating at least the flanged portion of the proximal retention structure and bonded to an upper surface of the septum.

### Claim 21 (depends on 20)

The device of claim 20, wherein the cover additionally encapsulates at least the proximal end region of the housing.

### Claim 22 (depends on 20)

The device of claim 20, wherein the cover additionally encapsulates and bonds to an upper end portion of the access opening.

### Claim 23 (depends on 20)

The device of claim 20, further comprising one or more surface features extending within at least an upper surface of the flanged portion of the proximal retention structure.

### Claim 24 (depends on 23)

The device of claim 23, wherein the cover extends within and bonds to the one or more surface features.

### Claim 25 (depends on 24)

The device of claim 24, wherein the one or more surface features comprises at least one of a through-hole extending from the upper surface to a lower surface of the flanged portion.

### Claim 26 (depends on 20)

The device of claim 20, wherein the cover and the septum are configured to be penetrated with a needle during filling of the reservoir chamber and to re-seal upon removal of the needle.

### Claim 27 (depends on 20)

The device of claim 20, wherein the septum is pre-molded and the cover is over-molded.

### Claim 28 (depends on 27)

The device of claim 27, wherein the septum is a soft, high strength material and the cover is a high durometer material.

### Claim 29 (depends on 28)

The device of claim 28, wherein the material of the septum is a liquid injection molding silicone elastomer and the material of the cover is a translucent, liquid silicone rubber.

### Claim 30 (depends on 28)

The device of claim 28, wherein the access opening is formed of a material more rigid than the material of the septum.

### Claim 31 (depends on 30)

The device of claim 30, wherein the septum is under a radial compressive force due to being over-sized relative to the access opening and held by the access opening in an adhesion-free manner.

### Claim 32 (depends on 31)

The device of claim 31, wherein the radial compressive force encourages re-sealing of the septum after penetration and removal of a needle from the septum.

### Claim 33 (depends on 32)

The device of claim 32, wherein the cover prevents withdrawal of the penetrable barrier in a proximal direction upon removal of the needle from the septum.

### Claim 34 (depends on 20)

The device of claim 20, wherein the septum further comprises surface treatments on an external surface.

### Claim 35 (depends on 20)

The device of claim 20, wherein the cover has a thickness that is 0.007″-0.025″.

### Claim 36 (depends on 20)

The device of claim 20, wherein the cover extends beyond an outer diameter of the flanged portion and upward from an upper surface of the flanged portion providing a higher profile to the retention structure.

### Claim 37 (depends on 20)

The device of claim 20, wherein the septum further comprises a distal region that is flared and positioned within a proximal end region of the reservoir.

### Claim 38 (depends on 20)

The device of claim 20, wherein the septum further comprises one or more tabs, a flared skirt, flange, rib or other feature.

### Claim 39 (depends on 20)

The device of claim 20, wherein the upon being implanted in the eye, the flanged portion extends along the sclera, the narrowed portion extends trans-sclerally and at least a portion of the reservoir in the housing is located within a vitreous humor of the eye.
